Fundraising Fox
/Companies
Sign in

OpiAID, LLC

1 known investors

Find your way into OpiAID, LLC

Sign up to see every warm intro you have to OpiAID, LLC

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the OpiAID, LLC team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

OpiAID offers an AI-powered recovery intelligence platform that combines EHR data with biometric data from commercial wrist-worn wearables and applies machine learning to quantify withdrawal symptoms and support clinical decision-making. It serves clinicians and clinics treating Opioid Use Disorder (MOUD/MAT), providing dashboards, alerts, and remote monitoring to improve patient retention and care.

AI & Machine LearningDigital HealthHealthtech

Founders & leadership

DRDavid Reeser
David ReeserFounderHe started OpiAID in 2018 and serves as principal investigator on a National Institute on Drug Abuse SBIR Fast Track award, in addition to reviewing SBIR grants for the National Institutes of Health. His other work in the substance use field includes founding roles with Breaking Barriers to Substance Use Recovery and the SUD Solutions Network, advisory positions with Innovations for Substance Use Disorders and the HerFund Project, and keynote speaking engagements.

Investors · 1

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase I2023$319.6K
National Institutes of Health (NIH)National Institutes of HealthPhase I2020$331.5K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does OpiAID, LLC do?
OpiAID offers an AI-powered recovery intelligence platform that combines EHR data with biometric data from commercial wrist-worn wearables and applies machine learning to quantify withdrawal symptoms and support clinical decision-making. It serves clinicians and clinics treating Opioid Use Disorder (MOUD/MAT), providing dashboards, alerts, and remote monitoring to improve patient retention and care.
Who founded OpiAID, LLC?
OpiAID, LLC was founded by David Reeser.
Who are OpiAID, LLC's investors?
OpiAID, LLC's investors include NC IDEA.